Create a Profile
Get In Touch Mobile
Accel Research Sites’ CEO interviewed by Orlando Business Journal on company’s growth
With demand for COVID vaccines and treatment continuing in 2021, Accel Research Sites has stayed on the cutting edge of growth, not only expanding options for patients and participants, but also expanding the company. Orlando Business Journal recently interviewed Accel’s CEO, Lora Parahovnik, on how the company has adjusted to thrive over the last year and plans for growth. Learn more here.
Ready to be part of healthcare history? Find the right clinical trial for you.